Androgenic miniaturization, perifollicular inflammation, impaired follicle cycling, and cellular senescence in the scalp can all be happening simultaneously which is why monotherapy rarely gives most people everything they want
Muscle Loss While patients lose fat, they often lose muscle mass too
Wegovy, which uses the same active molecule at a 2.4 mg dose and is FDA-approved specifically for chronic weight management, was excluded
But even louder is the silence around what happens after women get the seat
One of the inventors, Jens Juul Holst, told Wired in an interview that most people stop taking it after a couple of years because the lack of interest in food makes them "miserable"
Therapeutic interventions offered to these patients are still very limited